Enhanced cGAS‐STING Activation and Immune Response by LPDAM Platform‐Based Lapachone–Chemical–Photothermal Synergistic Therapy for Colorectal Cancer
- 19 March 2025
- journal article
- Published by Wiley in Advanced Healthcare Materials
- Vol. 14 (11) , e2403309
Abstract
The cGAS‐STING signaling pathway is a pivotal immune response mechanism that bridges tumor and immune cell interactions. This study describes a multifunctional LPDAM nanoplatform integrating Lapachone, polydopamine (PDA), and Mn2+, which synergistically kills tumor cells and activates the cGAS‐STING pathway, thereby inducing DC maturation and T cell activation to achieve potent antitumor immunity. In the tumor microenvironment, Lapachone generates H2O2 via the NAD(P)H:quinone oxidoreductase 1 (NQO1 enzyme), while Mn2+ catalyze H2O2 conversion into •OH through chemodynamic effects (CDT). The photothermal effects (PTT) of PDA further amplify this cascade reaction, producing reactive oxygen species (ROS) that damage tumor mitochondria and release mitochondrial DNA (mtDNA). The released mtDNA activates the cGAS‐STING pathway, while Mn2+ enhances the sensitivity of cGAS to mtDNA, leading to robust antitumor immunity. Concurrently, photothermal‐induced immunogenic cell death (ICD) promotes dendritic cells (DCs) maturation, further strengthening immune responses. Moreover, Mn2⁺ also serves as a contrast agent for T1‐weighted magnetic resonance imaging (MRI), offering precise tumor visualization. This study demonstrates that the LPDAM nanoplatform facilitates Lapachone/CDT/PTT synergistic therapy under MRI guidance, showcasing its potential as an innovative strategy for combined immunotherapy in clinical oncology.Keywords
Funding Information
- National Natural Science Foundation of China (82372958)
- Natural Science Foundation of Fujian Province (2022J02032, 2023J06032)
This publication has 42 references indexed in Scilit:
- Engineering an Organic Nanoplatform for Augmented PyroeletroimmunotherapyAdvanced Materials, 2024
- Peroxidase‐Like Nanozyme Activates the cGAS‐STING Pathway via ROS‐Induced mtDNA Release for Cancer ImmunotherapyAdvanced Functional Materials, 2024
- Photothermal Ferrotherapy – Induced Immunogenic Cell Death via Iron‐Based Ternary Chalcogenide Nanoparticles Against Triple‐Negative Breast CancerSmall, 2023
- Harnessing Nanomaterials for Cancer Sonodynamic ImmunotherapyAdvanced Materials, 2023
- In Situ STING‐Activating Nanovaccination with TIGIT Blockade for Enhanced Immunotherapy of Anti‐PD‐1‐Resistant TumorsAdvanced Materials, 2023
- A Carbon‐Carbon Bond Cleavage‐Based Prodrug Activation Strategy Applied to β‐Lapachone for Cancer‐Specific TargetingAngewandte Chemie International Edition, 2022
- Microenvironment-driven sequential ferroptosis, photodynamic therapy, and chemotherapy for targeted breast cancer therapy by a cancer-cell-membrane-coated nanoscale metal-organic frameworkBiomaterials, 2022
- Intelligent photothermal dendritic cells restart the cancer immunity cycle through enhanced immunogenic cell deathBiomaterials, 2021
- Chemodynamic Therapy via Fenton and Fenton‐Like Nanomaterials: Strategies and Recent AdvancesSmall, 2021
- Nanomedicine‐Based Immunotherapy for the Treatment of Cancer MetastasisAdvanced Materials, 2019